Literature DB >> 20920652

Annual incidence of atrial fibrillation and related factors in adults.

Yasuyuki Iguchi1, Kazumi Kimura, Kensaku Shibazaki, Junya Aoki, Kazuto Kobayashi, Kenichiro Sakai, Yuki Sakamoto.   

Abstract

The aim of this study was to investigate the annual incidence of atrial fibrillation (AF) and related factors from health surveys in 2006 and 2007. Participants (aged ≥ 40 years) were examined from annual health surveys provided by the Kurashiki Public Health Center twice, in 2006 and 2007. Participants were classified into 2 groups: a control group without AF in 2006 and 2007, and an AF group with documented AF in 2007 but not in 2006. Annual AF incidence (per 1,000 patient-years) was calculated, and baseline characteristics were compared between groups. Independent factors for new documented AF were analyzed using multivariate logistic regression modeling. Health surveys were performed for 30,449 participants in 2006 and 2007. Excluding 439 participants with AF in 2006, newly documented AF was observed in 278 participants (0.9%), while the control group comprised 29,732 participants. The overall incidence of newly documented AF was 9.3/1,000 patient-years. Newly documented AF was significantly associated with age ≥ 80 years (odds ratio [OR] 1.57, 95% confidence interval [CI] 1.20 to 2.06, p = 0.001), history of cardiac disease (OR 7.47, 95% CI 5.79 to 9.63, p < 0.001), increasing estimated glomerular filtration rate of 10 ml/min/1.73 m(2) (OR 0.93, 95% CI 0.87 to 0.99, p = 0.025), and hypercholesterolemia (OR 0.75, 95% CI 0.58 to 0.96, p = 0.023).
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20920652     DOI: 10.1016/j.amjcard.2010.06.030

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  Elevated glycated hemoglobin levels may increase the risk of atrial fibrillation in patients with diabetes mellitus.

Authors:  Yu-Fan Yang; Wen-Qing Zhu; Kuan Cheng; Qing-Xing Chen; Ye Xu; Yang Pang; Gui-Jian Liu; Jun-Bo Ge
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Paradoxical association of lipoprotein measures with incident atrial fibrillation.

Authors:  Samia Mora; Akintunde O Akinkuolie; Roopinder K Sandhu; David Conen; Christine M Albert
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-05-25

3.  Prediction of Atrial Fibrillation by B-type Natriuretic Peptide.

Authors:  Hiroyuki Takase; Yasuaki Dohi; Hiroo Sonoda; Genjiro Kimura
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 4.  Cell-cell junction remodeling in the heart: possible role in cardiac conduction system function and arrhythmias?

Authors:  Valeria Mezzano; Farah Sheikh
Journal:  Life Sci       Date:  2011-12-28       Impact factor: 5.037

5.  Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study.

Authors:  Faye L Lopez; Sunil K Agarwal; Richard F Maclehose; Elsayed Z Soliman; A Richey Sharrett; Rachel R Huxley; Suma Konety; Christie M Ballantyne; Alvaro Alonso
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-06

Review 6.  Review of screening studies for atrial fibrillation in rural populations of 11 countries.

Authors:  Alex I Gavino; Craig S McLachlan
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

7.  Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study.

Authors:  Alvaro Alonso; Xiaoyan Yin; Nicholas S Roetker; Jared W Magnani; Richard A Kronmal; Patrick T Ellinor; Lin Y Chen; Steven A Lubitz; Robyn L McClelland; David D McManus; Elsayed Z Soliman; Rachel R Huxley; Saman Nazarian; Moyses Szklo; Susan R Heckbert; Emelia J Benjamin
Journal:  J Am Heart Assoc       Date:  2014-10-07       Impact factor: 5.501

8.  Atrial fibrillation in the elderly.

Authors:  Roberto A Franken; Ronaldo F Rosa; Silvio Cm Santos
Journal:  J Geriatr Cardiol       Date:  2012-06       Impact factor: 3.327

9.  Prevalence and associating factors of atrial fibrillation in patients with hypertension: a nation-wide study.

Authors:  Rungroj Krittayaphong; Ram Rangsin; Bandit Thinkhamrop; Cameron Hurst; Suthee Rattanamongkolgul; Nintita Sripaiboonkij; Ahthit Yindeengam
Journal:  BMC Cardiovasc Disord       Date:  2016-03-22       Impact factor: 2.298

10.  Association of Lipid-Related Genetic Variants with the Incidence of Atrial Fibrillation: The AFGen Consortium.

Authors:  Faye L Norby; Samuel Adamsson Eryd; Maartje N Niemeijer; Lynda M Rose; Albert V Smith; Xiaoyan Yin; Sunil K Agarwal; Dan E Arking; Daniel L Chasman; Lin Y Chen; Mark Eijgelsheim; Gunnar Engström; Oscar H Franco; Jan Heeringa; George Hindy; Albert Hofman; Pamela L Lutsey; Jared W Magnani; David D McManus; Marju Orho-Melander; James S Pankow; Gull Rukh; Christina-Alexandra Schulz; André G Uitterlinden; Christine M Albert; Emelia J Benjamin; Vilmundur Gudnason; J Gustav Smith; Bruno H C Stricker; Alvaro Alonso
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.